AHA-BUCH

Ocular Angiogenesis
-26 %
Der Artikel wird am Ende des Bestellprozesses zum Download zur Verfügung gestellt.

Ocular Angiogenesis

 Ebook
Sofort lieferbar | Lieferzeit:3-5 Tage I

Unser bisheriger Preis:ORGPRICE: 274,95 €

Jetzt 202,29 €*

ISBN-13:
9781597450478
Einband:
Ebook
Seiten:
412
eBook Typ:
PDF
eBook Format:
PDF
Kopierschutz:
1 - PDF Watermark
Sprache:
Englisch
Beschreibung:

Leading academic and pharmaceutical researchers and clinicians from many disciplines synthesize and summarize current clinical and basic knowledge concerning abnormal growth of blood vessels in the eye, the cause of major neovascular eye diseases. The authors also identify and assess the most promising approaches with potential for commercial exploitation and discuss the challenges encountered in developing therapeutics for ocular neovascular diseases. Highlights include illuminating chapters on gene therapy and novel drug delivery systems and excellent summaries of the newest therapeutic approaches.
"I. Angiogenic Diseases



Age-Related Macular Degeneration

Curtis L. Hagedorn and Ron A. Adelman



Endogenous Angiogenic Inhibitors in Diabetic Retinopathy

Jian-Xing Ma and Sarah X. Zhang



Corneal Angiogenesis

Trevor R. Carmichael



Polypoidal Choroidal Vasculopathy

Nahoko Ogata and Kanji Takahashi



Myopic Choroidal Neovascularization

Kyoko Ohno-Matsui and Takashi Tokoro



Mechanisms of the Formation and Stability of Retinal Blood Vessels

Jonathan Stone, Trent Sandercoe, and Jan Provis



Neovascular Glaucoma

James C. Tsai and M. Bruce Shields



Eales' Disease

Jyotirmay Biswas



Angiogenesis and Ocular Tumorigenesis

Nader Sheibani and Daniel M. Albert



Genetics of Ocular Vascular Disease

Jacquie Greenberg, Ari Ziskind, and Stephen P. Daiger



II. Endogenous Promoters and Inhibitors of Angiogenesis



Vascular Endothelial Growth Factor and Retinal Diseases

Sam Dahr and Karl G. Csaky



The Role of Fibroblast Growth Factors in Ocular Angiogenesis

Andreas Bikfalvi and Sophie Javerzat



Control of Neovascularization and Cell Survival in the Eye by PEDF

Joyce Tombran-Tink and Colin J. Barnstable



Thrombospondin: Guarding the Clear View

Arin Aurora and Olga V. Volpert



Regulation of Ocular Angiogenesis by Matrix Proteases and Tissue Inhibitors of Metalloproteinases

Bela Anand-Apte



Integrins in Ocular Angiogenesis

Matthew R. Ritter and Martin Friedlander



Ocular Inflammation and Neovascularization

Chi-Chao Chan and Robert B. Nussenblatt



III. Therapeutics and Delivery for Angiogenic Eye Diseases



Anti-VEGF Therapies for Diseases of the Retina and Choroid

Ming Lu and Donald J. D'Amico



Anecortave Acetate: A Novel Ocular Angiostatic Agent

Stella M. Robertson, Alberta A. Davis, David C. Dahlin, and Abbot F. Clark



Gene Therapy for Neovascular Retinopathies

Brian J. Raisler, Kenneth I. Berns, and William W. Hauswirth



Noninvasive Delivery of DNA Into the Eye

John M. Nickerson, R. Keith Shuler, Jr., John B. Davies, Phyllis K. Dioguardi, Steven M. Wolchok, Vincent T. Ciavatta, Jeffrey H. Boatright, and Henry F. Edelhauser



Novel Drug Delivery Systems for Posterior Segment Ocular Disease

Heather Sheardown and W. Mark Saltzman



Index"
Leading academic and pharmaceutical researchers and clinicians from many disciplines synthesize and summarize current clinical and basic knowledge concerning abnormal growth of blood vessels in the eye, the cause of major neovascular eye diseases. The authors also identify and assess the most promising approaches with potential for commercial exploitation and discuss the challenges encountered in developing therapeutics for ocular neovascular diseases. Highlights include illuminating chapters on gene therapy and novel drug delivery systems and excellent summaries of the newest therapeutic approaches.